ARCHIVES

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

NIH Plans Consensus Conference On Ovarian Cancer April 5-7

January 28, 1994

DCBD Board Like Organ Systems Program But Not RFAs, Okays Program Announcement, Contract Concepts

November 20, 1987

AACR Academy Names 2014 Class of Fellows

April 4, 2014

Anti-NCI Forces Fail to Raid $70 Million from Cancer Program

September 26, 1975

DCIS With Higher Density May Increase Risk For Disease

October 29, 2010

Techniques Developing Out Of Virus research Leading To Improved Therapy, Early Diagnosis

March 4, 1977